PatientsVille.com Logo

PatientsVille

Tahor Side Effects

Common Tahor Side Effects


The most commonly reported Tahor side effects (click to view or check a box to report):

Myalgia (97)
Rhabdomyolysis (89)
Blood Creatine Phosphokinase Increased (68)
Cytolytic Hepatitis (61)
Tendon Rupture (47)
Cholestasis (45)
Pruritus (36)
Renal Failure Acute (36)
Gamma-glutamyltransferase Increased (34)
Muscular Weakness (31)
Thrombocytopenia (29)
Fall (29)
Transaminases Increased (28)
Fatigue (28)
Arthralgia (28)
Asthenia (26)
Vertigo (26)
Muscle Spasms (26)
Tendonitis (25)
Renal Failure (25)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Tahor Side Effects Reported to FDA

The following Tahor reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Tahor on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Dyspnoea, Abdominal Pain Upper, Gastritis, Liver Function Test Abnormal
This is a report of a 77-year-old female patient (weight: NA) from FR, suffering from the following symptoms/conditions: acute coronary syndrome, who was treated with Tahor (dosage: 10 Mg, Daily, start time: Aug 23, 2013), combined with:
  • Brilique (90 Mg, 2x/day)
  • Kardegic (75 Mg, Daily)
  • Pantoprazole (40 Mg, Daily)
  • Bisoprolol (2.5 Mg, Daily)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Dyspnoea
  • Abdominal Pain Upper
  • Gastritis
  • Liver Function Test Abnormal
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tahor treatment in female patients, resulting in dyspnoea side effect. The patient was hospitalized.

Mixed Liver Injury, Hypocholesterolaemia, Confusional State, Multi-organ Failure, Pneumocystis Jirovecii Pneumonia
This report suggests a potential Tahor Mixed Liver Injury, Hypocholesterolaemia, Confusional State, Multi-organ Failure, Pneumocystis Jirovecii Pneumonia side effect(s) that can have serious consequences. A 77-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: aortic thrombosis and used Tahor (dosage: 40 Mg, Daily) starting Dec 31, 2013. Soon after starting Tahor the patient began experiencing various side effects, including:
  • Mixed Liver Injury
  • Hypocholesterolaemia
  • Confusional State
  • Multi-organ Failure
  • Pneumocystis Jirovecii Pneumonia
Drugs used concurrently: NA.The patient was hospitalized. Although Tahor demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as mixed liver injury, may still occur.

Interstitial Lung Disease
This Interstitial Lung Disease problem was reported by a health professional from FR. A 85-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On 201310 this consumer started treatment with Tahor (dosage: 10 Mg, 1x/day). The following drugs were being taken at the same time:
  • Cordarone (1 Df, 5x /week)
  • Fludex (1 Df, 1x/day)
  • Levothyrox (37.5 Ug, 1x/day)
  • Kardegic (160 Mg, 1x/day)
  • Fosamax (70 Mg, Weekly)
  • Orocal (Unk)
  • Kaleorid (Unk)
When commencing Tahor, the patient experienced the following unwanted symptoms/side effects:
  • Interstitial Lung Disease
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as interstitial lung disease, may become evident only after a product is in use by the general population.

Rhabdomyolysis, Renal Failure Acute, Pneumonia, Sepsis
This is a report of a 83-year-old male patient (weight: NA) from FR. The patient developed the following symptoms/conditions: NA and was treated with Tahor (dosage: 10 Mg, Daily) starting Dec 23, 2013. Concurrently used drugs:
  • Fucidine (6 Df, Daily)
  • Lasilix (Unk)
  • Topalgic (Unk)
  • Fumafer (Unk)
  • Triatec (Unk)
  • Oflocet (Unk)
  • Lantus (Unk)
  • Pradaxa (Unk)
Soon after that, the consumer experienced the following side effects:
  • Rhabdomyolysis
  • Renal Failure Acute
  • Pneumonia
  • Sepsis
The patient was hospitalized. This opens a possibility that Tahor treatment could cause the above reactions, including rhabdomyolysis, and some male subjects may be more susceptible.


Cerebrovascular Accident, Hepatocellular Injury
A 60-year-old female patient (weight: NA) from DZ with the following symptoms/conditions: prophylaxis started Tahor treatment (dosage: 80 Mg, Unk) on NS. Soon after starting Tahor treatment, the subject experienced various side effects, including:
  • Cerebrovascular Accident
  • Hepatocellular Injury
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Tahor.

Pancreatitis Acute, Escherichia Bacteraemia, Blood Calcium Decreased
A 65-year-old male patient from FR (weight: NA) experienced symptoms, such as: dyslipidaemia,fungal infection,benign prostatic hyperplasia and was treated with Tahor(dosage: 10 Mg, Daily). The treatment was initiated on Jan 11, 2014. After that a consumer reported the following side effect(s):
  • Pancreatitis Acute
  • Escherichia Bacteraemia
  • Blood Calcium Decreased
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Tahor efficacy:
  • Terbinafine (250 Mg, Daily)
  • Xatral (10 Mg, Daily)
  • Finasteride (5 Mg, Daily)
  • Finasteride (10 Mg, Daily)
  • Helicidine (Unk)
The patient was hospitalized.

Colon Cancer, Intestinal Obstruction
In this report, Tahor was administered for the following condition: hypercholesterolaemia.A 65-year-old male consumer from FR (weight: NA) started Tahor treatment (dosage: 40 Mg, Unk) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Colon Cancer
  • Intestinal Obstruction
A possible interaction with other drugs could have contributed to this reaction:
  • Metformin Hcl
  • Atorvastatine Teva (40 Mg, Unk)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Tahor treatment could be related to the listed above side effect(s).

Hypocholesterolaemia
This is a report of the following Tahor side effect(s):
  • Hypocholesterolaemia
A 79-year-old female patient from FR (weight: NA) presented with the following condition: hypercholesterolaemia,hypertension and received a treatment with Tahor (dosage: 20 Mg, Daily) starting: Dec 11, 2013.The following concurrently used drugs could have generated interactions:
  • Amlor (5 Mg, Daily)
  • Eupressyl (30 Mg, 2x/day)
  • Altizide W/spironolactone (1 Df, Daily)
  • Lodoz (1 Df (10 Mg/6.25 Mg), Daily)
  • Novonorm (1 Mg, 3x/day)
  • Glivec (400 Mg, Daily)
  • Glivec (Unk)
This report suggests that a Tahor treatment could be associated with the listed above side effect(s).

Rhabdomyolysis, Cholestasis, Hyponatraemia, Hypoalbuminaemia, Renal Failure
This Tahor report was submitted by a 64-year-old female consumer from FR (weight: NA). The patient was diagnosed with: NA and Tahor was administered (dosage: 80 Mg, Daily) starting: 2013. The consumer developed a set of symptoms:
  • Rhabdomyolysis
  • Cholestasis
  • Hyponatraemia
  • Hypoalbuminaemia
  • Renal Failure
Other drugs used simultaneously:
  • Inipomp (20 Mg, Daily)
  • Domperidone (10 Mg)
  • Domperidone
  • Kardegic (75 Mg, Daily)
  • Novonorm (1 Mg, 3x/day)
  • Lantus (12 Iu, 1x/day (every 24 Hours))
Those unexpected symptoms could be linked to a Tahor treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Product Substitution Issue, Myalgia, Arthralgia, Abdominal Pain, Nausea, Diarrhoea, Alopecia
This is a report of a possible correlation between Tahor use and the following symptoms/side effect(s):
  • Product Substitution Issue
  • Myalgia
  • Arthralgia
  • Abdominal Pain
  • Nausea
  • Diarrhoea
  • Alopecia
which could contribute to an assessment of Tahor risk profile.A 74-year-old female consumer from FR (weight: NA) was suffering from NA and was treated with Tahor (dosage: 20 Mg, 1x/day) starting 201209.Other concurrent medications:
  • Atorvastatin Mylan (20 Mg, 1x/day)


Gout
A 83-year-old female patient from FR (weight: NA) presented with the following symptoms: NA and after a treatment with Tahor (dosage: 80 Mg, 1x/day) experienced the following side effect(s):
  • Gout
The treatment was started on Jun 26, 2013. Tahor was used in combination with the following drugs:
  • Paroxetine (20 Mg, 1x/day)
  • Dafalgan (1 G, 4x/day (500 Mg Capsule))
  • Lasilix Faible (20 Mg, 1x/day)
  • Atenolol (50 Mg, 1x/day)
  • Kardegic (160 Mg, 1x/day)
This report could alert potential Tahor consumers.

Pancytopenia
In this report, a 64-year-old male patient from FR (weight: NA) was affected by a possible Tahor side effect.The patient was diagnosed with NA. After a treatment with Tahor (dosage: 10 Mg, Daily, start date: NS), the patient experienced the following side effect(s):
  • Pancytopenia
The following simultaneously used drugs could have led to this reaction:
  • Janumet ([50 Mg Sitagliptin/ 1000 Mg Metformin], 2 Df, Daily)
  • Aprovel (150 Mg, Daily)
  • Gliclazide (30 Mg, Daily)
  • Pariet (10 Mg, Daily)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Tahor treatment.

Myalgia, Gait Disturbance
This is a report of a 59-year-old male patient from FR (weight: NA), who used Tahor (dosage: Unk) for a treatment of prophylaxis. After starting a treatment on 200108, the patient experienced the following side effect(s):
  • Myalgia
  • Gait Disturbance
The following drugs could possibly have interacted with the Tahor treatment NA.Taken together, these observations suggest that a Tahor treatment could be related to side effect(s), such as Myalgia, Gait Disturbance.

Rash, Pruritus, Staphylococcal Infection
This rash side effect was reported by a health professional from FR. A 64-year-old male patient (weight:NA) experienced the following symptoms/conditions: dyslipidaemia. The patient was prescribed Tahor (dosage: 20 Mg, 1x/day), which was started on Dec 03, 2013. Concurrently used drugs: NA. When starting to take Tahor the consumer reported the following symptoms:
  • Rash
  • Pruritus
  • Staphylococcal Infection
These side effects may potentially be related to Tahor.

Ascites, Oedema Peripheral
This is a Tahor side effect report of a 55-year-old male patient (weight:NA) from FR, suffering from the following symptoms/conditions: NA, who was treated with Tahor (dosage:40 Mg, 1x/day, start time: 201312), combined with:
  • Neoral (25 Mg, 2x/day)
  • Cellcept (1 G, 2x/day)
  • Cortancyl (5 Mg, Daily)
  • Lasilix (80 Mg, Unk)
  • Lasilix (250 Mg, Unk)
  • Lasilix (325 Mg, Unk)
  • Valaciclovir (500 Mg, 2x/day)
  • Bactrim (0.25 Df, Daily)
, and developed a serious reaction and a ascites side effect. The patient presented with:
  • Ascites
  • Oedema Peripheral
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Tahor treatment in male patients suffering from NA, resulting in ascites.

Rhabdomyolysis
This report suggests a potential Tahor rhabdomyolysis side effect(s) that can have serious consequences. A 57-year-old male patient from FR (weight:NA) was diagnosed with the following health condition(s): NA and used Tahor (dosage: 10 Mg, Daily) starting Dec 17, 2013. Soon after starting Tahor the patient began experiencing various side effects, including:
  • Rhabdomyolysis
Drugs used concurrently:NA. The patient was hospitalized. Although Tahor demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as rhabdomyolysis, may still occur.

Colitis Ulcerative, Movement Disorder, Feeding Disorder, Stress, Vomiting, Diarrhoea, Weight Decreased
This colitis ulcerative problem was reported by a physician from FR. A 62-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): dyslipidaemia,type 2 diabetes mellitus,pain.On Feb 25, 2006 a consumer started treatment with Tahor (dosage: 10 Mg, Daily). The following drugs/medications were being taken at the same time: NA. When commencing Tahor, the patient experienced the following unwanted symptoms /side effects:
  • Colitis Ulcerative
  • Movement Disorder
  • Feeding Disorder
  • Stress
  • Vomiting
  • Diarrhoea
  • Weight Decreased
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as colitis ulcerative, may become evident only after a product is in use by the general population.

Agranulocytosis
This is a Tahor side effect report of a 78-year-old male patient (weight: NA) from FR. The patient developed the following symptoms/conditions: NA and was treated with Tahor (dosage: 40 Mg, Daily) starting Oct 26, 2013. Concurrently used drugs:
  • Inexium (Unk)
Soon after that, the consumer experienced the following of symptoms:
  • Agranulocytosis
The patient was hospitalized. This opens a possibility that Tahor could cause agranulocytosis and that some male patients may be more susceptible.

Abdominal Pain Upper, Pancreatitis Acute
A 58-year-old female patient (weight: NA) from FR with the following symptoms: infarction started Tahor treatment (dosage: 40 Mg, 1x/day) on NS. Soon after starting Tahor treatment, the consumer experienced several side effects, including:
  • Abdominal Pain Upper
  • Pancreatitis Acute
. Concurrently used drugs:
  • Inipomp (20 Mg, 1x/day)
  • Lasilix Faible (20 Mg, 1x/day)
  • Kardegic
  • Triatec
  • Doliprane
  • Topalgic
  • Previscan
  • Ventoline
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Tahor side effects, such as abdominal pain upper.

Interstitial Lung Disease, Pneumonia Staphylococcal, Bacteraemia
This interstitial lung disease side effect was reported by a health professional from FR. A 71-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Tahor (dosage: 10 Mg, 1x/day), which was started on 2010. Concurrently used drugs:
  • Neoral
  • Cortancyl
  • Lasilix
  • Inipomp
  • Levothyrox
  • Uvedose
  • Detensiel
.When starting to take Tahor the consumer reported symptoms, such as:
  • Interstitial Lung Disease
  • Pneumonia Staphylococcal
  • Bacteraemia
These side effects may potentially be related to Tahor. The patient was hospitalized.

Leukocytosis
This is a report of a 52-year-old male patient (weight: NA) from FR, suffering from the following symptoms/conditions: NA, who was treated with Tahor (dosage: Unk, start time: Sep 25, 2013), combined with:
  • Clozapine (25 Mg, Daily)
  • Clozapine (75 Mg, Daily)
  • Clozapine (100 Mg, Daily)
  • Clozapine (150 Mg, Daily)
  • Clozapine (200 Mg, Daily)
  • Clozapine (250 Mg, Daily)
  • Hydroxyzine Hydrochloride (300 Mg, Daily)
  • Lorazepam (5 Mg, Daily)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Leukocytosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Tahor treatment in male patients, resulting in leukocytosis side effect. The patient was hospitalized.

Gastrointestinal Haemorrhage, Haemorrhagic Anaemia, Overdose, Renal Failure Acute, Metabolic Acidosis
This report suggests a potential Tahor Gastrointestinal Haemorrhage, Haemorrhagic Anaemia, Overdose, Renal Failure Acute, Metabolic Acidosis side effect(s) that can have serious consequences. A 73-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: hypercholesterolaemia,antiphospholipid syndrome,myocardial infarction,cardiac failure,hypertension,type 2 diabetes mellitus and used Tahor (dosage: 80 Mg, Daily) starting NS. Soon after starting Tahor the patient began experiencing various side effects, including:
  • Gastrointestinal Haemorrhage
  • Haemorrhagic Anaemia
  • Overdose
  • Renal Failure Acute
  • Metabolic Acidosis
Drugs used concurrently:
  • Previscan (For Inr Between 2 And 3)
  • Kardegic (75 Mg, 1x/day)
  • Lasilix (40 Mg, Daily)
  • Perindopril (4 Mg, Daily)
  • Galvus (50 Mg, 2x/day)
  • Amlodipine Besilate (5 Mg, Daily)
  • Levothyrox (50 Ug, Unk)
  • Cetirizine Actavis (10 Mg, Daily)
The patient was hospitalized. Although Tahor demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gastrointestinal haemorrhage, may still occur.

Rash, Eosinophilia, Renal Failure Acute, Pyrexia, Fall, Meningeal Disorder, Face Injury, Multiple Fractures
This Rash, Eosinophilia, Renal Failure Acute, Pyrexia, Fall, Meningeal Disorder, Face Injury, Multiple Fractures problem was reported by a health professional from FR. A 78-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension,prophylaxis. On Dec 06, 2013 this consumer started treatment with Tahor (dosage: 10 Mg, 1x/day). The following drugs were being taken at the same time:
  • Augmentin (1 G, 3x/day)
  • Lercan (10 Mg, 1x/day)
  • Lamictal (50 Mg, 2x/day)
  • Lamictal (Unk)
  • Levothyrox (Unk)
When commencing Tahor, the patient experienced the following unwanted symptoms/side effects:
  • Rash
  • Eosinophilia
  • Renal Failure Acute
  • Pyrexia
  • Fall
  • Meningeal Disorder
  • Face Injury
  • Multiple Fractures
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as rash, may become evident only after a product is in use by the general population.

Myalgia, Asthenia, Hepatocellular Injury
This is a report of a 56-year-old female patient (weight: NA) from FR. The patient developed the following symptoms/conditions: NA and was treated with Tahor (dosage: 20 Mg, 1x/day) starting Nov 06, 2013. Concurrently used drugs:
  • Fucidine (500 Mg, 3x/day)
Soon after that, the consumer experienced the following side effects:
  • Myalgia
  • Asthenia
  • Hepatocellular Injury
This opens a possibility that Tahor treatment could cause the above reactions, including myalgia, and some female subjects may be more susceptible.

Linear Iga Disease
A 84-year-old male patient (weight: NA) from FR with the following symptoms/conditions: dyslipidaemia started Tahor treatment (dosage: 40 Mg, Daily) on Sep 06, 2013. Soon after starting Tahor treatment, the subject experienced various side effects, including:
  • Linear Iga Disease
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Tahor.

1 of 39 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Tahor Side Effects

    Did You Have a Tahor Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Tahor for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Tahor Safety Alerts, Active Ingredients, Usage Information

    More About Tahor

    Side Effects reported to FDA: 956

    Tahor safety alerts: No

    Reported deaths: 58

    Reported hospitalizations: 477

    Latest Tahor clinical trials

    Tahor Reviews

    No reviews, be a first to report a side effect via side effect reporting form